Welcome to the official LinkedIn page for CREXONT®, a novel formulation of extended-release carbidopa and levodopa. Please see Important Safety Information on LinkedIn page and the full Prescribing Information here: https://amneal.com/pi/crexont.pdf
Indication
CREXONT® (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of the brain, or Parkinson’s disease-like symptoms that may result from carbon monoxide or manganese poisoning in adults.
IMPORTANT SAFETY INFORMATION
Do not take CREXONT with antidepressant medications known as nonselective monoamine oxidase (MAO) inhibitors.
Do not take CREXONT with other carbidopa-levodopa preparations without consulting your healthcare provider.
CREXONT may cause falling asleep during activities of daily living, somnolence, or dizziness. Avoid activities that require alertness such as driving and operating machinery until you know how CREXONT affects you.
The most common side effects that may occur with CREXONT are nausea and anxiety.
Use in Specific Populations
Pregnancy: Based on animal data, CREXONT may cause fetal harm. There are no adequate data on the developmental risk associated with the use of CREXONT in pregnant women.
Breastfeeding: The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for CREXONT.
Geriatric patients: There were no differences in safety outcomes between patients less than 65 years of age, 65-75 years of age, or 75 years and older.
To report SUSPECTED ADVERSE REACTIONS, contact Amneal Specialty, a division of Amneal Pharmaceuticals, LLC at 1‑877‑835‑5472 or the FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.
PP-CREX-US-0011 1/2025
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://crexont.com/
- Keywords
- Grand Rapids.
- Competitors
- Northwest Parkinson's Foundation, Piramal Pharma Ltd, Johnson & Johnson Innovative Medicine, Aidan Medical Products, Inc., Amneal Pharmaceuticals, Anthem Biosciences Limited, VABYSMOⓇ (faricimab-svoa), Quest Diagnostics, Life Sciences Trainers & Educators Network (LTEN), Teva Pharmaceuticals.
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules Questions
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules's website is https://crexont.com/
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules's LinkedIn profile is https://www.linkedin.com/company/crexont
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules's industry is
Pharmaceutical Manufacturing
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules's top competitors are
Northwest Parkinson's Foundation,
Piramal Pharma Ltd,
Johnson & Johnson Innovative Medicine,
Aidan Medical Products, Inc.,
Amneal Pharmaceuticals,
Anthem Biosciences Limited,
Vabysmoⓡ (Faricimab-Svoa),
Quest Diagnostics,
Life Sciences Trainers & Educators Network (Lten),
Teva Pharmaceuticals.
Crexont® (Carbidopa And Levodopa) Extended-Release Capsules's categories are Pharmaceutical Manufacturing
